SANOFICONR — Sanofi Consumer Healthcare India Income Statement
0.000.00%
Last trade - 00:00- IN₹113.87bn
- IN₹110.76bn
- IN₹7.25bn
- 86
- 10
- 83
- 66
Annual income statement for Sanofi Consumer Healthcare India, fiscal year end - December 31st, INR millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IAS | IAS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 5,554 | 7,245 |
| Cost of Revenue | ||
| Gross Profit | 4,033 | 5,383 |
| Selling / General / Administrative Expenses | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 3,402 | 4,868 |
| Operating Profit | 2,152 | 2,377 |
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | 2,193 | 2,468 |
| Provision for Income Taxes | ||
| Net Income After Taxes | 1,649 | 1,810 |
| Net Income Before Extraordinary Items | ||
| Net Income | 1,649 | 1,810 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | 1,649 | 1,810 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 72.2 | 87.6 |
| Dividends per Share |